[(18)F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma

PURPOSE: To investigate the utility of [(18)F]FDG-PET as an imaging biomarker for pathological response early upon neoadjuvant immune checkpoint blockade (ICB) in patients with head and neck squamous cell carcinoma (HNSCC) before surgery. METHODS: In the IMCISION trial (NCT03003637), 32 patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Vos, Joris L., Zuur, Charlotte L., Smit, Laura A., de Boer, Jan Paul, Al-Mamgani, Abrahim, van den Brekel, Michiel W. M., Haanen, John B. A. G., Vogel, Wouter V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016016/
https://www.ncbi.nlm.nih.gov/pubmed/34957526
http://dx.doi.org/10.1007/s00259-021-05610-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016016/
https://www.ncbi.nlm.nih.gov/pubmed/34957526
http://dx.doi.org/10.1007/s00259-021-05610-x

Ejemplares similares